Utama › Narkolepsi › Texas
Kajian klinikal Narkolepsi di Texas
6 kajian untuk Narkolepsi sedang mencari peserta di lokasi di Texas.
Bandar di Texas
Teks kajian rasmi (Bahasa Inggeris)
A Study to Investigate the Effects of Cleminorexton Compared With Placebo in the Treatment of Participants With Central Disorders of Hypersomnolence
- Austin, Texas, Austin
- Dallas, Texas, Dallas
- Houston, Texas, Houston
- dan 2 lagi
Mengambil pesertaFasa 2/3
Umur 18 hingga 70 · Semua jantina · Dikemas kini 2 Okt 2026 · NCT07598708A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1
- Alkermes Investigational Site, Austin
- Alkermes Investigational Site, San Antonio
- Alkermes Investigational Site, Sugar Land
Mengambil pesertaFasa 3
Umur 18 hingga 70 · Semua jantina · Dikemas kini 3 Sep 2026 · NCT07455383A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Narcolepsy
- Aayus Research, Austin
- Southwest Family Medicine, Dallas
- Metroplex Pulmonary and Sleep Center, McKinney
- dan 3 lagi
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 27 Ogo 2026 · NCT07675135A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia
- Alkermes Investigational Site, Austin
- Alkermes Investigational Site, San Antonio
- Alkermes Investigational Site, Sugar Land
Mengambil pesertaFasa 2/3
Umur 18 hingga 70 · Semua jantina · Dikemas kini 7 Ogo 2026 · NCT06767683A Study to Evaluate the Efficacy and Safety of E2086 in Adults With Narcolepsy
- Future Search Trials of Neurology, Austin
- Sleep Therapy and Research Center, San Antonio
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 14 Mei 2026 · NCT07493265A Long-term Extension Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia
- Austin, Texas, Austin
- El Paso, Texas, El Paso
Mengambil pesertaFasa 2
Umur 18 hingga 65 · Semua jantina · Dikemas kini 16 Apr 2026 · NCT07096674Daripada ClinicalTrials.gov, data diperoleh pada 4 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.